SPWYX Mutual Fund

SPWYX Mutual Fund

NAV$17.00
See how much of SPWYX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$154M
Expense Ratio
1.05%
Dividend Yield (Current)
-
Holdings
98
Inception Date
Feb 24, 2012
Fund Family
American Beacon Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+14.29%
1 Year+11.57%
3 Year+20.51%
5 Year+3.99%
10 Year+12.26%

Asset Allocation

Stocks: 98.29%
Cash: 1.71%
See how much of SPWYX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
HALOHalozyme Therapeutics Inc2.03%
LGNDLigand Pharmaceuticals Inc1.99%
RGENRepligen Corp1.93%
FCFSFirstcash Inc1.91%
XMTRXometry Inc Class A1.88%
Top 10 Concentration: 18.55%Report Date: Aug 31, 2026
Download all 98 holdings for SPWYX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$3.68
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

SPWYX Mutual Fund Overview

SPWYX Mutual Fund (American Beacon Stephens Small Cap growth Fund Y Class) is managed by American Beacon Funds with $154.5M in net assets. SPWYX expense ratio is 1.05%, holding 98 positions across sectors including Information Technology, Health Care, Industrials. Inception date: 2012-02-24.

SPWYX performance shows a YTD return of 14.29%. The 1-year return is 11.57% and the 5-year return is 3.99%.

SPWYX top holdings include Halozyme Therapeutics Inc (2.0%), Ligand Pharmaceuticals Inc (2.0%), Repligen Corp (1.9%), Firstcash Inc (1.9%), Xometry Inc Class A (1.9%). Go to all SPWYX holdings, SPWYX sectors, or SPWYX dividends.

SPWYX can be compared against other funds. Use SPWYX overlap to find shared positions, or SPWYX vs another fund for a side-by-side view. SPWYX alternatives are available via the screener, along with tax-loss harvesting opportunities.